The 8 analysts offering 1 year price forecasts for SZD have a max estimate of — and a min estimate of —.
Analyst rating
Based on 8 analysts giving stock ratings to SZD in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
SZD EPS for the last quarter is 0.15 EUR despite the estimation of 0.14 EUR. In the next quarter EPS is expected to reach 0.16 EUR. Track more of SANTEN PHARMA. financials and stay on top of what is up with the company.
In the next quarter SANTEN PHARMA. revenue is expected to reach 468.59 M EUR. Check out SANTEN PHARMA. revenue and earnings and make informed decisions.
According to analysts, SZD price target is 13.14 EUR with a max estimate of 16.27 EUR and a min estimate of 10.64 EUR. Check if this forecast comes true in a year, meanwhile watch SANTEN PHARMA. stock price chart and keep track of the current situation with SZD news and stock market news.
We've gathered opinions of 8 analysts rating SZD stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.